Medpace Holdings, Inc. — Director's Dealing 2018

Mar 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2018-02-28

Reporting Person: GEIGER JESSE J (CFO & COO, Lab Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-30	Common Stock	A	7407	—	Acquired	7407	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-28	Employee Stock Option (Right to Buy)	$32.05	A	15000	Acquired	2025-02-28	Common Stock (15000)	Direct

Footnotes

F1: Shares acquired by an in-kind exchange of Issuer shares for investment units of Medpace Investors, LLC originally acquired by the Reporting Person upon exercise of Issuer options. The options, once exercised, were immediately exchanged for investment units in Medpace Investors, LLC as required by the Medpace Holdings, Inc. 2014 Equity Incentive Plan.

F2: The option vests on February 28, 2022, subject to the Reporting Person's continued employment with the Issuer.